Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant

被引：0
|
作者：
Mirza, Sayeef [1 ]
Tandon, Ankita [1 ]
Jenneman, Dakota [1 ]
Cao, Shu [1 ]
Kumar, Ambuj [2 ]
Kidd, Michelle R. [3 ]
Khimani, Farhad [4 ]
Mishra, Asmita [4 ]
Liu, Hien D. [5 ]
Nishihori, Taiga [6 ]
Perez, Lia [4 ]
Bejanyan, Nelli [4 ,6 ]
Pidala, Joseph [4 ]
Nieder, Michael [4 ]
Elmariah, Hany [4 ]
机构：
[1] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA
[2] Univ S Florida, Program Comparat Effectiveness Res, Morsani Coll Med, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5673
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
    Mirza, Abu-Sayeef
    Tandon, Ankita
    Jenneman, Dakota
    Cao, Shu
    Brimer, Thomas
    Kumar, Ambuj
    Kidd, Michelle
    Khimani, Farhad
    Faramand, Rawan
    Mishra, Asmita
    Liu, Hien
    Nishihori, Taiga
    Perez, Lia
    Lazaryan, Aleksandr
    Bejanyan, Nelli
    Nieder, Michael
    Anasetti, Claudio
    Pidala, Joseph
    Elmariah, Hany
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 185.e1 - 185.e7
  • [2] Outcomes in Elderly Hematopoietic Stem Cell Transplant Patients Receiving Tacrolimus Graft-Versus-Host Disease Prophylaxis
    Griffin, Meagan
    Zheng, Junting
    Lin, Andrew
    Maloy, Molly
    Glezerman, Ilya
    Jakubowski, Ann A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S198 - S198
  • [3] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
    Mattsson, J.
    Svenberg, P.
    Gustafsson, B.
    Remberger, M.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
  • [4] Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance
    Puckrin, Robert
    Kwan, Alex Chi Fung
    Blosser, Nikki
    Leyshon, Catherine
    Duggan, Peter
    Daly, Andrew
    Zepeda, Victor
    Stewart, Douglas
    Chaudhry, Ahsan
    Storek, Jan
    Jamani, Kareem
    CYTOTHERAPY, 2023, 25 (10) : 1101 - 1106
  • [5] Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis
    Yoshikawa, Naoki
    Ehara, Yukina
    Yamada, Yusei
    Matsusaki, Yuki
    Shimoda, Kazuya
    Ikeda, Ryuji
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [6] Evaluation of Tacrolimus Levels and Risk of Acute Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant
    Huynh, David Anh Huy
    Freeman, Tracelyn
    Marshall, Vincent
    Markstrom, Denise
    Frame, David
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [7] Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
    Snyder, David S.
    Palmer, Joycelynne
    Gaal, Karl
    Stein, Anthony S.
    Pullarkat, Vinod
    Sahebi, Firoozeh
    Vora, Nyana
    Nakamura, Ryotaro
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : 281 - 286
  • [8] Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease
    Greco, Raffaella
    Barbanti, Maria Chiara
    Forcina, Alessandra
    Stanghellini, Maria Teresa Lupo
    Giglio, Fabio
    Morelli, Mara
    Vago, Luca
    Piemontese, Simona
    Messina, Carlo
    Sala, Elisa
    Pavesi, Francesca
    Marktel, Sarah
    Carrabba, Matteo G.
    Assanelli, Andrea
    Bernardi, Massimo
    Peccatori, Jacopo
    Corti, Consuelo
    Ciceri, Fabio
    BLOOD, 2015, 126 (23)
  • [9] A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
    Torlen, Johan
    Ringden, Olle
    Garming-Legert, Karin
    Ljungman, Per
    Winiarski, Jacek
    Remes, Kari
    Itala-Remes, Maija
    Remberger, Mats
    Mattsson, Jonas
    HAEMATOLOGICA, 2016, 101 (11) : 1417 - 1425
  • [10] Sirolimus and tacrolimus as graft-versus-host disease prophylaxis in allogeneic stem cell transplantation: The Dana Farber Cancer Institute experience
    Cutler, C
    Li, S
    Kim, HT
    Alyea, E
    Ho, V
    Lee, SJ
    Soiffer, R
    Antin, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 3 - 4
12345